Health care startups that raised Series A in Asia
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| CHOSEN by Dermatology | Chennai | Series A | $5.0M | 2026-10-28 |
| My Benefit | Seocho | Series A | $2.3M | 2026-10-19 |
| Aibo Medical Robot | Shenzhen | Series A | $14.1M | 2026-10-15 |
| Salary Hero | Bangkok | Series A | $7.6M | 2026-10-14 |
| Sunfox Technologies | Dehra Dun | Series A | $7.0M | 2026-10-07 |
| Amaani | Dubai | Series A | $5.0M | 2026-09-28 |
| Apollon | Seoul | Series A | $3.7M | 2026-09-22 |
| Josan-shes | Tokyo | Series A | $2.6M | 2026-09-15 |
8 rows of the CSV in 5 of its 18 columns.
- The 1,855 health care startups in Asia whose last round is Series A have raised $13.7B in total.
- 241 of them closed their most recent round in the last 12 months, $2.1B combined.
- The largest of those rounds is Syremis Therapeutics' $165.0M Series A, dated December 2025.
- The most recent is Afana Biotechnology's $50.0M Series A on 6 November 2026.
- TIPS Program is an investor in 17 of them, more than any other fund.
- Biotech is the most common other sector, with 582 companies (31%).
- 28% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (45% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 1,855| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| CHOSEN by Dermatology | CHOSEN by Dermatology develops clinical skincare, haircare, and wellness products for skin concerns. | Health care | Chennai, India | Series A | $5.0M | 2026-10-28 | $6.3M | Peak XV Partners | 51 to 100 | 2020 |
| My Benefit | My Benefit offers a digital platform for tracking musculoskeletal conditions and fitness levels. | Health care | Seocho, South Korea | Series A | $2.3M | 2026-10-19 | $5.3M | We Ventures | 11 to 50 | 2005 |
| Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen, China | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| Salary Hero | Salary Hero provides a financial health platform for employees. | Fintech | Bangkok, Thailand | Series A | $7.6M | 2026-10-14 | $10.4M | 500 Global, Global Founders Capital, 500 TukTuks +2 | 11 to 50 | 2021 |
| Sunfox Technologies | Sunfox Technologies operates a research and development lab focused on accessible technology. | Hardware | Dehra Dun, India | Series A | $7.0M | 2026-10-07 | $9.5M | Venture Catalysts, LVX Ventures, Mumbai Angels | 101 to 250 | 2016 |
| Amaani | Amaani builds beauty and wellness brands from the Middle East, including its flagship brand AÏZA. | Health care | Dubai, United Arab Emirates | Series A | $5.0M | 2026-09-28 | $11.0M | Peak XV Partners | 1 to 10 | 2023 |
| Apollon | Apollon develops noninvasive continuous glucose monitoring systems. | Artificial intelligence | Seoul, South Korea | Series A | $3.7M | 2026-09-22 | $6.4M | TIPS Program, KB Investment, TheVentures +2 | 11 to 50 | 2021 |
| Josan-shes | Josan-shes is a web platform connecting women and families with nursing, babysitting, and childcare services. | Health care | Tokyo, Japan | Series A | $2.6M | 2026-09-15 | $3.6M | East Ventures, Partners Fund | 2021 | |
| Medulance | Medulance offers a GPS-based platform for fast, reliable first-point medical attention. | Hardware | New Delhi, India | Series A | $2.5M | 2026-09-04 | $5.8M | Alkemi Growth Capital | 101 to 250 | 2016 |
| Lissun | Lissun provides a platform for scalable mental and emotional health support. | Health care | Gurgaon, India | Series A | $5.0M | 2026-08-18 | $8.9M | Inflection Point Ventures, We Founder Circle, Rainmatter Capital +1 | 101 to 250 | 2021 |
| Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan, Israel | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Beijing, China | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| Tianhu Technology | Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. | Artificial intelligence | Minhang, China | Series A | $29.0M | 2026-07-13 | $54.2M | Qiming Venture Partners, GSR United Capital, 3E Bioventures | 11 to 50 | 2021 |
| Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Hangzhou, China | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
| Lingtai Krypton Biotechnology | Lingtai Krypton Biotechnology develops lncRNA drugs to treat human diseases. | Biotech | Shuangliu, China | Series A | $13.7M | 2026-06-26 | $13.7M | Legend Capital, Guosheng Capital, Firefly Haoyue | 11 to 50 | 2021 |
| Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen, China | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| MoleculeMind | MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. | Artificial intelligence | Haidian, China | Series A | $86.0M | 2026-06-17 | $114.6M | Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital | 51 to 100 | 2022 |
| Haimai Medical | Haimai Medical develops tissue engineering and regenerative medicine technologies. | Health care | Suzhou, China | Series A | $14.3M | 2026-06-12 | $14.3M | IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 | 51 to 100 | 2021 |
| Dioseve | Dioseve produces egg cells using DIOLs to create more reproductive possibilities. | Biotech | Tokyo, Japan | Series A | $6.2M | 2026-06-11 | $15.5M | ANRI, Coral Capital, Archetype Ventures +2 | 11 to 50 | 2021 |
| Sehat Kahani | Sehat Kahani connects patients with doctors online, delivers lab services at home, and ships medicines to customers. | Health care | Karachi, Pakistan | Series A | $2.7M | 2026-06-09 | $4.2M | Epic Angels, Mentors Fund, CrossFund | 101 to 250 | 2017 |
| Degron Therapeutics | Degron Therapeutics discovers molecular glue degraders for cancer treatment. | Biotech | Shanghai, China | Series A | $40.0M | 2026-05-14 | $94.0M | Baidu Ventures, BioVenture, New Alliance Capital +2 | 101 to 250 | 2021 |
| Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Shenzhen, China | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| HyugaLife | HyugaLife sells authentic, quality health and wellness products through its e-commerce platform. | Commerce | Mumbai, India | Series A | $10.6M | 2026-04-28 | $11.6M | Stride Ventures, GetVantage | 101 to 250 | 2020 |
| Amaha (formerly InnerHour) | Amaha provides a technology-led omnichannel mental health platform addressing the treatment gap in India. | Health care | Mumbai, India | Series A | $5.3M | 2026-03-30 | $16.9M | Fireside Ventures, Lightbox, Capricorn Ventures | 101 to 250 | 2016 |
| Neurodome | Neurodome manufactures non-invasive deep brain nerve modulation technology and products. | Biotech | Xian Shi, China | Series A | $14.5M | 2026-03-12 | $14.5M | Shunwei Capital, Frees Fund, Oriza Holdings +2 | 11 to 50 | 2019 |
| Celloid | Celloid supplies a 3D cell culture medium that supports quality-controlled long-term cultivation of organoids. | Biotech | Seongnam, South Korea | Series A | $6.1M | 2026-03-12 | $7.9M | FuturePlay, POSTECH Holdings | 1 to 10 | 2021 |
| iCamumo | iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. | Biotech | Suzhou, China | Series A | $14.4M | 2026-03-09 | $75.2M | Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment | 51 to 100 | 2021 |
| Oncare Cancer | Oncare provides cancer therapies grounded in the latest research and studies. | Health care | New Delhi, India | Series A | $3.0M | 2026-02-23 | $4.0M | Cloud Capital, Huddle, DeVC +1 | 11 to 50 | 2023 |
| Daffodil Health | Daffodil Health operates a paediatric behavioural health platform. | Health care | Bangalore, India | Series A | $16.3M | 2026-02-17 | $20.9M | EPIC Ventures, Maverick Ventures, Conquest | 1 to 10 | 2020 |
| Care.Fi | Care.Fi provides smart financing solutions to hospitals, doctors, and allied suppliers. | Fintech | Gurgaon, India | Series A | $5.0M | 2026-02-11 | $13.1M | Trifecta Capital Advisors, Climber Capital | 11 to 50 | 2021 |
Table 1. Health care startups that raised Series A in Asia: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,855.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MoleculeMind | MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. | Artificial intelligence | Haidian, China | Series A | $86.0M | 2026-06-17 | $114.6M | Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital | 51 to 100 | 2022 |
| 2 | Allink Biotherapeutics | Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. | Biotech | Shanghai, China | Series A | $47.0M | 2025-12-16 | $89.0M | Legend Capital, Gaorong Capital, BioVenture +2 | 11 to 50 | 2023 |
| 3 | Degron Therapeutics | Degron Therapeutics discovers molecular glue degraders for cancer treatment. | Biotech | Shanghai, China | Series A | $40.0M | 2026-05-14 | $94.0M | Baidu Ventures, BioVenture, New Alliance Capital +2 | 101 to 250 | 2021 |
| 4 | Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan, Israel | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| 5 | Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Beijing, China | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| 6 | Tianhu Technology | Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. | Artificial intelligence | Minhang, China | Series A | $29.0M | 2026-07-13 | $54.2M | Qiming Venture Partners, GSR United Capital, 3E Bioventures | 11 to 50 | 2021 |
| 7 | Daffodil Health | Daffodil Health operates a paediatric behavioural health platform. | Health care | Bangalore, India | Series A | $16.3M | 2026-02-17 | $20.9M | EPIC Ventures, Maverick Ventures, Conquest | 1 to 10 | 2020 |
| 8 | Moxie Beauty | Moxie Beauty makes and sells haircare products for a range of hair types and concerns. | Health care | Gurgaon, India | Series A | $15.0M | 2025-12-16 | $17.1M | Fireside Ventures | 1 to 10 | 2022 |
| 9 | Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen, China | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| 10 | Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Hangzhou, China | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
Table 2. Health care startups that raised Series A in Asia: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | TIPS Program | Startup incubator | Gangneung, South Korea | 17 | 1% | 2 | Apollon, Seeann Solution |
| 2 | Peak XV Partners | Venture capital firm | Bangalore, India | 8 | 0% | 3 | CHOSEN by Dermatology, Amaani, Saladin |
| 3 | BioVenture | Venture capital firm | Suzhou, China | 8 | 0% | 2 | Degron Therapeutics, Allink Biotherapeutics |
| 4 | 500 Global | Startup accelerator | Palo Alto, United States | 7 | 0% | 1 | Salary Hero |
| 5 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 7 | 0% | 2 | Tianhu Technology, Prime Lifescience |
| 6 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 7 | 0% | 1 | MoleculeMind |
| 7 | ANRI | Venture capital firm | Tokyo, Japan | 6 | 0% | 2 | Dioseve, Cosomil |
| 8 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 5 | 0% | 2 | Aibo Medical Robot, MoleculeMind |
| 9 | KB Investment | Private equity firm | Seoul, South Korea | 5 | 0% | 1 | Apollon |
| 10 | East Ventures | Venture capital firm | 5 | 0% | 1 | Josan-shes | |
| 11 | Kakao Ventures | Venture capital firm | Seongnam, South Korea | 5 | 0% | 1 | Goi |
| 12 | ZhenFund | Entrepreneurship program | Beijing, China | 5 | 0% | ||
| 13 | Matrix Partners China | Venture capital firm | Beijing, China | 5 | 0% | ||
| 14 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 4 | 0% | 1 | Aibo Medical Robot |
| 15 | Fireside Ventures | Micro VC fund | Bangalore, India | 4 | 0% | 2 | Amaha (formerly InnerHour), Moxie Beauty |
Table 3. Health care startups that raised Series A in Asia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 582 | 31% | $7.0B |
| Software | 282 | 15% | $1.7B |
| Artificial intelligence | 140 | 8% | $1.2B |
| Hardware | 103 | 6% | $443.4M |
| Commerce | 66 | 4% | $138.8M |
| Fintech | 51 | 3% | $1.4B |
| Education | 26 | 1% | $76.1M |
| Energy | 7 | 0% | $60.6M |
| Cybersecurity | 4 | 0% |
Table 4. Health care startups that raised Series A in Asia by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 1,855 | 100% | $4.5M |
Table 5. Health care startups that raised Series A in Asia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
Table 6. Health care startups that raised Series A in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Health care startups that raised Series A in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 4 | 2% | $50.0M |
| October 2026 | 20 | 8% | $174.2M |
| September 2026 | 14 | 6% | $101.4M |
| August 2026 | 17 | 7% | $203.2M |
| July 2026 | 14 | 6% | $175.5M |
| June 2026 | 21 | 9% | $260.1M |
| May 2026 | 19 | 8% | $219.6M |
| April 2026 | 13 | 5% | $68.4M |
| March 2026 | 16 | 7% | $100.5M |
| February 2026 | 16 | 7% | $47.9M |
| January 2026 | 36 | 15% | $171.2M |
| December 2025 | 32 | 13% | $380.8M |
| November 2025 | 19 | 8% | $126.5M |
Table 8. Health care startups that raised Series A in Asia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 190 | 10% | $1.6B |
| 2025 | 254 | 14% | $1.9B |
| 2024 | 184 | 10% | $1.0B |
| 2023 | 192 | 10% | $1.1B |
| 2022 | 184 | 10% | $1.7B |
| 2021 | 157 | 8% | $1.6B |
Table 9. Health care startups that raised Series A in Asia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 72 | 4% |
| 2020 to 2022 | 430 | 24% |
| 2015 to 2019 | 744 | 41% |
| 2010 to 2014 | 359 | 20% |
| Before 2010 | 217 | 12% |
Table 10. Health care startups that raised Series A in Asia by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 252 | 16% |
| 11 to 50 | 700 | 45% |
| 51 to 100 | 268 | 17% |
| 101 to 250 | 186 | 12% |
| 251 to 500 | 83 | 5% |
| 501 to 1,000 | 32 | 2% |
| 1,001 to 5,000 | 20 | 1% |
| 5,001 to 10,000 | 2 | 0% |
| 10,001 or more | 7 | 0% |
Table 11. Health care startups that raised Series A in Asia by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in Asia. On 16 November 2026 that is 1,855 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 1,855 rows: 543 have no round amount, 0 no city and 683 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Asia whose last round is Series A are on the list?
- 1,855, in the file dated 16 November 2026. 241 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 1,855 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.